CM336

CM336 · Keymed Biosciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CM336, covering 2024-10-15 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate CM336 in Adults With Autoimmune Bullous Disease [Phase 2]